FDA Issues Warnings for ADHD Drugs
If you, or someone you care about, take an Attention Deficit Hyperactivity Disorder (ADHD) medication, be aware of the potentially serious side effects. The Food and Drug Administration (FDA) has asked ADHD drug manufacturers to develop Patient Medication Guides outlining serious cardiovascular and psychiatric risks.
The ADHD medication in question includes the following products:
- Adderall XR
- Focalin XR
- Metadate CD
- Ritalin SR
- Ritalin LA
The adverse cardiovascular risks linked to ADHD drugs could lead to such complications as heart attack, stroke, and even sudden death. The adverse psychiatric risks could lead to such complications as hearing voices, mania, and paranoia. The risk of experiencing these symptoms may be increased by family history of similar complications. However, especially in the case of psychiatric effects, problems may surface with no previous medical history.
Source: "FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Events." FDA Press Release. February 21, 2007.